| | | | | | | RegenMD | | | | | | | | | | | | | | | | 3:07 pm, March 21, 2011----Research in the areas of drug delivery and tissue engineering has witnessed tremendous progress in recent years due to its unlimited potential to improve human health. Smart biomaterials with nanoscale organizations, ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | Like stem cell-fuelled regenerative medicine and genetic therapy, nanotechnology offers immense potential for improving the health of humans – and little practical realization of that promise yet. Still, Toronto scientists have offered a fascinating ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | ... Forbion and Easton Capital, it has hired Chief Scientific Officer Mitchell Finer, formerly of stem-cell regenerative medicine company Novocell Inc. (now ViaCyte Inc.), of San Diego, Calif., and boosted employees from a handful to 25 people. ... See all stories on this topic » | Mass High Tech | | | | | | | | | | | | | | |
No comments:
Post a Comment